Joung et al. revealed that four genes, programmed death-ligand 1 (PD-L1), MCL-1, JunB proto-oncogene (JUNB), and β1,3-N-acetylglucosaminyltransferases (B3GNT2), affect the interaction of cancer cells with T cells, conferring resistance to T cell cytotoxicity[64]. This evidence concerns the gene MCL1 and cancer.